Search research articles
Contact Us
Filters
Showing results (321-330 of 341) with videos related to
Page
of 35
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation
Daniel N Cagney, Allison M Martin, Paul J Catalano, et al.
Radiology. Artificial Intelligence
|
July 10, 2024
Stepwise Transfer Learning for Expert-level Pediatric Brain Tumor MRI Segmentation in a Limited Data Scenario
Aidan Boyd, Zezhong Ye, Sanjay P Prabhu, et al.
Cancer Immunology Research
|
November 24, 2020
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1
Rupal S Bhatt, Abdulla Berjis, Julie C Konge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2018
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma
Jonathan D Schoenfeld, Evisa Gjini, Scott J Rodig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
Daniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
World Neurosurgery
|
November 25, 2018
Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis
Nayan Lamba, Daniel N Cagney, Rachel H Brigell, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Plos One
|
April 10, 2015
High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets
Orison O Woolcott, Joyce M Richey, Morvarid Kabir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
Pamela L Kunz, Noah T Graham, Paul J Catalano, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 341) with videos related to
Sort By:
Page
of 35
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
February 6, 2018
Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation
Daniel N Cagney, Allison M Martin, Paul J Catalano, et al.
Radiology. Artificial Intelligence
|
July 10, 2024
Stepwise Transfer Learning for Expert-level Pediatric Brain Tumor MRI Segmentation in a Limited Data Scenario
Aidan Boyd, Zezhong Ye, Sanjay P Prabhu, et al.
Cancer Immunology Research
|
November 24, 2020
KIR3DL3 Is an Inhibitory Receptor for HHLA2 that Mediates an Alternative Immunoinhibitory Pathway to PD1
Rupal S Bhatt, Abdulla Berjis, Julie C Konge, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 2, 2018
Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma
Jonathan D Schoenfeld, Evisa Gjini, Scott J Rodig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2005
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials
Daniel J Sargent, Harry S Wieand, Daniel G Haller, et al.
World Neurosurgery
|
November 25, 2018
Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis
Nayan Lamba, Daniel N Cagney, Rachel H Brigell, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Plos One
|
April 10, 2015
High-fat diet-induced insulin resistance does not increase plasma anandamide levels or potentiate anandamide insulinotropic effect in isolated canine islets
Orison O Woolcott, Joyce M Richey, Morvarid Kabir, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 20, 2022
Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2022
Randomized Study of Temozolomide or Temozolomide and Capecitabine in Patients With Advanced Pancreatic Neuroendocrine Tumors (ECOG-ACRIN E2211)
Pamela L Kunz, Noah T Graham, Paul J Catalano, et al.
Page
of 35